Clinical Response: Doctors might change the dose based on how well the patient is doing
MHRA Threat to clinics In communication with the MHRA, they also stated: However, we do have concerns about the level of clinical oversight present in IV vitamin therapy and injection services in general and the appropriacy of such services is currently under review. This review, if deciding on stopping treatment of B12 injections by clinics who do comply with the ridiculous rules of the MHRA, would not only negatively impact the companies and individuals who give B12 injections, but also to the people who rely on them to keep functioning both physically and mentally
However, if serum cobalamin concentration is within the normal range, treatment should be continued at least monthly and the owner should be forewarned that clinical signs may recur sometime in the future
Standardized Formulation Each capsule contains 500mcg of BPC-157 and 500mcg of TB-500, creating a consistent 1000mcg research peptide blend capsule format for laboratory research and development use
May Benefit Your Brain by Preventing the Loss of Neurons
This process improves blood pressure and cholesterol levels, which lower heart disease risk
